Bryant J. Yates
Known title: EVP & President, EuropeCIK: 0001385324
Associated companies
Transaction History
| NATR | ▼ Sell | Open Market | 11,968 | $238K | 6/5/2026 | View on chart |
| NATR | ▲ Buy | Grant | 8,753 | $0 | 5/15/2026 | View on chart |
| NATR | ▲ Buy | Option Exercise | 1,634 | $0 | 5/5/2026 | View on chart |
| NATR | ▼ Sell | Tax Withholding | 472 | $12K | 5/5/2026 | View on chart |
| NATR | ▲ Buy | Option Exercise | 2,448 | $0 | 5/5/2026 | View on chart |
| NATR | ▼ Sell | Tax Withholding | 707 | $18K | 5/5/2026 | View on chart |
| NATR | ▲ Buy | Option Exercise | 2,716 | $0 | 5/5/2026 | View on chart |
| NATR | ▼ Sell | Tax Withholding | 784 | $20K | 5/5/2026 | View on chart |
| NATR | ▼ Sell | Tax Withholding | 1,567 | $42K | 4/20/2026 | View on chart |
| NATR | ▼ Sell | Open Market | 19,516 | $475K | 3/13/2026 | View on chart |
| NATR | ▼ Sell | Tax Withholding | 1,103 | $27K | 3/11/2026 | View on chart |
| NATR | ▼ Sell | Tax Withholding | 1,459 | $37K | 3/10/2026 | View on chart |
| NATR | ▼ Sell | Other | 7,761 | — | 3/6/2026 | View on chart |
| NATR | ▲ Buy | Option Exercise | 1,317 | $0 | 3/6/2026 | View on chart |
| NATR | ▼ Sell | Tax Withholding | 450 | $11K | 3/6/2026 | View on chart |
| NATR | ▲ Buy | Grant | 7,761 | $194K | 3/6/2026 | View on chart |
| NATR | ▼ Sell | Open Market | 1,700 | $38K | 12/12/2025 | View on chart |
| NATR | ▼ Sell | Tax Withholding | 354 | $5K | 11/4/2025 | View on chart |
| NATR | ▲ Buy | Option Exercise | 2,716 | $0 | 11/4/2025 | View on chart |
| NATR | ▼ Sell | Tax Withholding | 780 | $11K | 11/4/2025 | View on chart |
| NATR | ▲ Buy | Option Exercise | 1,224 | $0 | 11/4/2025 | View on chart |
| NATR | ▼ Sell | Open Market | 4,672 | $78K | 8/29/2025 | View on chart |
| NATR | ▼ Sell | Open Market | 5,000 | $84K | 8/26/2025 | View on chart |
| NATR | ▼ Sell | Tax Withholding | 1,738 | $26K | 7/21/2025 | View on chart |
| NATR | ▼ Sell | Tax Withholding | 1,201 | $17K | 3/11/2025 | View on chart |
| NATR | ▲ Buy | Grant | 12,810 | $189K | 3/10/2025 | View on chart |
| NATR | ▼ Sell | Tax Withholding | 1,553 | $24K | 7/21/2024 | View on chart |
| NATR | ▼ Sell | Open Market | 3,068 | $47K | 6/6/2024 | View on chart |
| NATR | ▼ Sell | Tax Withholding | 1,864 | $36K | 4/20/2024 | View on chart |
| NATR | ▼ Sell | Tax Withholding | 898 | $18K | 3/26/2024 | View on chart |
| NATR | ▲ Buy | Grant | 10,532 | $0 | 3/11/2024 | View on chart |
| NATR | ▲ Buy | Option Exercise | 15,000 | $208K | 8/29/2023 | View on chart |
| NATR | ▼ Sell | Open Market | 15,000 | $252K | 8/29/2023 | View on chart |
| NATR | ▼ Sell | Tax Withholding | 1,553 | $21K | 7/21/2023 | View on chart |
| NATR | ▼ Sell | Open Market | 1,767 | $21K | 6/9/2023 | View on chart |
| NATR | ▼ Sell | Open Market | 2,630 | $32K | 6/8/2023 | View on chart |
| NATR | ▼ Sell | Open Market | 1,315 | $15K | 6/5/2023 | View on chart |
| NATR | ▼ Sell | Open Market | 618 | $7K | 6/2/2023 | View on chart |
| NATR | ▼ Sell | Open Market | 1,638 | $18K | 6/1/2023 | View on chart |
| NATR | ▼ Sell | Open Market | 1,500 | $17K | 5/25/2023 | View on chart |
| NATR | ▲ Buy | Grant | 16,294 | $0 | 4/20/2023 | View on chart |
| NATR | ▼ Sell | Tax Withholding | 1,848 | $19K | 3/30/2023 | View on chart |
| NATR | ▼ Sell | Tax Withholding | 776 | $8K | 3/26/2023 | View on chart |
| NATR | ▲ Buy | Grant | 15,909 | $0 | 7/21/2022 | View on chart |
| NATR | ▲ Buy | Option Exercise | 2,716 | — | 4/6/2022 | View on chart |
| NATR | ▼ Sell | Tax Withholding | 662 | $11K | 4/6/2022 | View on chart |
| NATR | ▼ Sell | Tax Withholding | 844 | $14K | 3/30/2022 | View on chart |
| NATR | ▼ Sell | Tax Withholding | 614 | $11K | 3/26/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 29, 2026
Nature's Sunshine Q2 Earnings Reviewed Against Peers
A recent analysis compared Nature's Sunshine's second-quarter results with other personal care companies. This review helps investors understand how the stock performed relative to its sector during that period. The company currently trades with a trailing P/E ratio of 13.3, while analysts maintain an average price target of $30.50.
Nature's Sunshine Q2 Earnings Reviewed Against Peers. A recent analysis compared Nature's Sunshine's second-quarter results with other personal care companies. This review helps investors understand how the stock performed relative to its sector during that period. The company currently trades with a trailing P/E ratio of 13.3, while analysts maintain an average price target of $30.50.